Plain-English translation of NCT06801262 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are testing a new blood test called the TreaT assay to help detect when a transplanted kidney is being rejected by the body's immune system. This test uses samples from urine and blood to identify immune cells that attack the donor kidney, which could help doctors personalize immunosuppressive therapy (the drugs that prevent rejection). Early results suggest the test may predict kidney rejection and help preserve kidney function after transplant.
After a kidney transplant, patients must take strong immune-suppressing medications to prevent their body from attacking the new organ, but these drugs have serious side effects. Doctors need a better way to identify which patients are at highest risk for rejection so they can adjust medication doses based on individual need rather than using a one-size-fits-all approach.
You likely qualify if…
You likely don't qualify if…
If you are a transplant patient, you would provide urine and blood samples collected through standard clinical procedures at your transplant center. The study is non-interventional, meaning researchers are only observing and testing your samples — you will not receive any experimental medication or undergo any special procedures beyond routine post-transplant care. Your samples help researchers understand how well the new blood test works at detecting kidney rejection.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
Italy
Enrollment target
~150 participants
Started
November 2022
Primary completion
May 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in January 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Gaetano La Manna, MD
IRCCS Azienza Ospedaliero-Universitaria di Bologna
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.